Blog

Descovy is non-inferior to Truvada for daily PrEP

[From aidmap,  March 6, 2019]

“A daily pill containing the newer formulation of tenofovir in combination with emtricitabine (Descovy)had a comparable protective effect to the existing daily pill which contains the older tenofovir and emtricitabine (Truvada), Dr Brad Hare of the Kaiser Permanente San Francisco Medical Center told the Conference on Retroviruses and Opportunistic Infections (CROI 2019) in Seattle today. As expected, the newer formulation had better bone and kidney safety outcomes.”

For more, click here.